References
- Roila F, Tonato M, Basurto C, et al. Protection from nausea and vomiting in cisplatin-treated patients: High-dose metoclo-pramide combined with dexamethasone and diphenhy-dramine: A study of the Italian Oncology Group for Clinical Research. J. Clin Oncol 1989; 7: 1693–700
- Roila F, Bracarda S, Lupatteli M., et al. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis. Eur J. Caneer 1992; 27: 119–21
- Kris M G, Gralla R J, Clark R A, Tyson L B, Groshen S. Antiemetic control and prevention of side-effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Cancer 1987; 60: 2816–22
- Kris M G, Gralla R J, Tyson L B, Cirrincione C, Groshen S. Controlling delayed vomiting: Doubled-blinded, randomized trial comparing placebo, dexamethasone alone, and metoclo-pramide plus dexamethasone in patients receiving cisplatin. J. Clin Oncol 1989; 7: 108–14
- Warr D, Wilan A, Venner P, et al. A randomised, double-blind comparison of granisetron with high-dose metoclo-pramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trial Group Phase III Trial. Eur J Cancer 1993; 27a: 33–6
- Gralla R. Antiematic drugs for chemotherapeutic support. Current treatment and rationale for development of newer agents. Cancer 1992; 70(Suppl.)1003–6
- Marschner N W, Adler M, Nagel G A, Christmann D, Fenzi E, Upadhyaya B. Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclo-pramide in advanced breast cancer patients treated with epiru-bicin and cyclophosphamide. Eur J Cancer 1991; 27: 1137–40
- Diaz-Rubio E, Martin M, Rosell R, Valerdi J J, Gonzalez-Larriba J L, Barriga J J. The antiemetic efficacy of thiethylper-azine and methylprednisolone versus thierylperazine and placebo in breast cancer patients treated with adjuvant chemotherapy (fluorouracil, doxorubicin and cyclophosphamide). A randomized, double-blind, cross-over trial. Acta Oncol 1991; 30: 339–42
- Smith D B, Newlands E S, Rustin G JS, et al. Comparison of ondansetron and ondansetron plus dexamethasone as an-timetic prophylaxis during cisplatin-contaimng chemotherapy. Lancet 1991; 338: 487–90
- Altman D G. Clinical trials. Anonymous. Practical statistics for medical research. Chapman & Hall, London 1991; 440–75
- Jones A L, Hill A S, Soukop M, et al. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338: 483–7